Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invaryant is a private U.S. healthcare technology company that provides a patient-centric, real-time, real-world data platform for healthcare providers, life sciences organizations, and patients. Its core offering integrates medical records, wellness data, device data, and patient-reported information into a normalized data environment designed to support clinical development, post-market surveillance, and patient safety programs. The company markets solutions for decentralized and hybrid clinical trials, REMS and other risk-management programs, provider interoperability, and personal health record management. Invaryant positions its platform as a compliant, patented technology stack that works alongside existing healthcare and clinical research systems rather than as a drug developer. Overall, the company is best understood as a commercial health-tech and life-sciences software platform focused on data interoperability, safety, and regulatory workflow enablement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invaryant.